Jim Calandriello

Jim Calandriello serves as the Vice President of Underwriting at Prime Therapeutics since December 2022, bringing extensive experience in the healthcare sector. Previously, Jim held the same title at Magellan Health from September 2019 to December 2022 and at Express Scripts from January 2011 to June 2019, where management included a team of 50 pricing analysts and actuaries responsible for underwriting substantial financial offers. Early career roles included Senior Director and Director of Underwriting at Medco Health Solutions from January 2008 to 2011, and Senior Manager and Senior Financial Analyst positions prior to that. Jim's academic background includes a Bachelor of Arts in History from Rutgers University and a Master of Business Administration in Finance from Centenary University.